Press ReleaseHIV RT Inhibitor Azvudine Received IND ApprovalZhengzhou, China – May 18, 2013, Zhengzhou Granlen PharmaTech Ltd, a Division of Granlen LLC in San Diego, California, ...
POST：2013-05-30
Zhengzhou, China – March17, 2017, Zhengzhou Granlen PharmaTech, Ltd., a Division of Granlen, Inc. inSan Diego, CA, USA, announced the publication of newly discovered...
POST：2017-03-17
Zhengzhou, China – January 12, 2018, Zhengzhou Granlen PharmaTech, Ltd., a Division of Granlen, Inc. in San Diego, CA, USA, announced the publication of azido-nucleosides by...
POST：2018-01-17
San Diego, USand Zhengzhou, China –August 14, 2016.Granlen, Inc., San Diego and ZhengzhouGranlen PharmaTech Ltd. announced today that Dr. P. Dan Cook was appointed astheir global ...
POST：2016-08-14
Zhengzhou, China – February 15, 2016, Zhengzhou Granlen PharmaTech, Ltd., a Division ofGranlen, Inc. in San Diego, CA, USA, will present newly discovered Continued Equality at 251...
POST：2016-02-15
Zhengzhou, China – April 10, 2015, Zhengzhou Granlen PharmaTech Ltd, aDivision of Granlen, Inc. in San Diego, California, USA, will present the newlydiscovered and developed...
POST：2015-04-10
Zhengzhou, China – January 28, 2013, Zhengzhou Granlen PharmaTech Ltd, a Division of Granlen LLC in San Diego, California, USA, announced today it has accomplished the full scale ...
POST：2013-01-28
Another News and Events: Dr. Haoyun An participated the International Marathon in April, 2012.
POST：2012-06-29
Dr. Haoyun (Harry) An gave a keynote speech entitled “Critical Application of Modern Equipment and Analytical Methodologies in New Drug Discovery and Development” on the “16th...
POST：2012-05-19
Current page:1/1 [1]
© 1998 - 2022 Granlen Inc. All Rights Reserved 豫ICP备19022032号-1
